Global Cancer Drug Therapy Market Growth 2020-2025
According to this study, over the next five years the Cancer Drug Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Drug Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Drug Therapy market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cancer Drug Therapy, covering the supply chain analysis, impact assessment to the Cancer Drug Therapy market size growth rate in several scenarios, and the measures to be undertaken by Cancer Drug Therapy companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Targeted Therapy
Chemotherapy
Immunotherapy
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen / Allergan
Bristol-Myers Squibb
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
AstraZeneca
Merck
Exelixis
Roche
Incyte
Prometheus Labs
Eisai
Novartis
Genentech (Roche)
Pfizer
Exelixis
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Drug Therapy consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cancer Drug Therapy market by identifying its various subsegments.
Focuses on the key global Cancer Drug Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Drug Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Drug Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Drug Therapy Consumption 2015-2025
2.1.2 Cancer Drug Therapy Consumption CAGR by Region
2.2 Cancer Drug Therapy Segment by Type
2.2.1 Targeted Therapy
2.2.2 Chemotherapy
2.2.3 Immunotherapy
2.3 Cancer Drug Therapy Consumption by Type
2.3.1 Global Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Drug Therapy Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Drug Therapy Sale Price by Type (2015-2020)
2.4 Cancer Drug Therapy Segment by Application
2.4.1 Angiogenesis Inhibitors
2.4.2 mTOR Inhibitors
2.4.3 Monoclonal Antibodies
2.4.4 Cytokine Immunotherapy (IL-2)
2.5 Cancer Drug Therapy Consumption by Application
2.5.1 Global Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Drug Therapy Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Drug Therapy Sale Price by Type (2015-2020)
3 Global Cancer Drug Therapy by Company
3.1 Global Cancer Drug Therapy Sales Market Share by Company
3.1.1 Global Cancer Drug Therapy Sales by Company (2018-2020)
3.1.2 Global Cancer Drug Therapy Sales Market Share by Company (2018-2020)
3.2 Global Cancer Drug Therapy Revenue Market Share by Company
3.2.1 Global Cancer Drug Therapy Revenue by Company (2018-2020)
3.2.2 Global Cancer Drug Therapy Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Drug Therapy Sale Price by Company
3.4 Global Cancer Drug Therapy Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Drug Therapy Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Drug Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Drug Therapy by Regions
4.1 Cancer Drug Therapy by Regions
4.2 Americas Cancer Drug Therapy Consumption Growth
4.3 APAC Cancer Drug Therapy Consumption Growth
4.4 Europe Cancer Drug Therapy Consumption Growth
4.5 Middle East & Africa Cancer Drug Therapy Consumption Growth
5 Americas
5.1 Americas Cancer Drug Therapy Consumption by Countries
5.1.1 Americas Cancer Drug Therapy Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Drug Therapy Value by Countries (2015-2020)
5.2 Americas Cancer Drug Therapy Consumption by Type
5.3 Americas Cancer Drug Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cancer Drug Therapy Consumption by Regions
6.1.1 APAC Cancer Drug Therapy Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Drug Therapy Value by Regions (2015-2020)
6.2 APAC Cancer Drug Therapy Consumption by Type
6.3 APAC Cancer Drug Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cancer Drug Therapy by Countries
7.1.1 Europe Cancer Drug Therapy Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Drug Therapy Value by Countries (2015-2020)
7.2 Europe Cancer Drug Therapy Consumption by Type
7.3 Europe Cancer Drug Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cancer Drug Therapy by Countries
8.1.1 Middle East & Africa Cancer Drug Therapy Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Drug Therapy Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Drug Therapy Consumption by Type
8.3 Middle East & Africa Cancer Drug Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Drug Therapy Distributors
10.3 Cancer Drug Therapy Customer
11 Global Cancer Drug Therapy Market Forecast
11.1 Global Cancer Drug Therapy Consumption Forecast (2021-2025)
11.2 Global Cancer Drug Therapy Forecast by Regions
11.2.1 Global Cancer Drug Therapy Forecast by Regions (2021-2025)
11.2.2 Global Cancer Drug Therapy Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Drug Therapy Forecast by Type
11.8 Global Cancer Drug Therapy Forecast by Application
12 Key Players Analysis
12.1 Amgen / Allergan
12.1.1 Company Information
12.1.2 Cancer Drug Therapy Product Offered
12.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Amgen / Allergan Latest Developments
12.2 Bristol-Myers Squibb
12.2.1 Company Information
12.2.2 Cancer Drug Therapy Product Offered
12.2.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bristol-Myers Squibb Latest Developments
12.3 Argos Therapeutics
12.3.1 Company Information
12.3.2 Cancer Drug Therapy Product Offered
12.3.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Argos Therapeutics Latest Developments
12.4 Aveo Pharmaceuticals
12.4.1 Company Information
12.4.2 Cancer Drug Therapy Product Offered
12.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Aveo Pharmaceuticals Latest Developments
12.5 Bayer
12.5.1 Company Information
12.5.2 Cancer Drug Therapy Product Offered
12.5.3 Bayer Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bayer Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Cancer Drug Therapy Product Offered
12.6.3 AstraZeneca Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Merck
12.7.1 Company Information
12.7.2 Cancer Drug Therapy Product Offered
12.7.3 Merck Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merck Latest Developments
12.8 Exelixis
12.8.1 Company Information
12.8.2 Cancer Drug Therapy Product Offered
12.8.3 Exelixis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Exelixis Latest Developments
12.9 Roche
12.9.1 Company Information
12.9.2 Cancer Drug Therapy Product Offered
12.9.3 Roche Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Roche Latest Developments
12.10 Incyte
12.10.1 Company Information
12.10.2 Cancer Drug Therapy Product Offered
12.10.3 Incyte Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Incyte Latest Developments
12.11 Prometheus Labs
12.11.1 Company Information
12.11.2 Cancer Drug Therapy Product Offered
12.11.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Prometheus Labs Latest Developments
12.12 Eisai
12.12.1 Company Information
12.12.2 Cancer Drug Therapy Product Offered
12.12.3 Eisai Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Eisai Latest Developments
12.13 Novartis
12.13.1 Company Information
12.13.2 Cancer Drug Therapy Product Offered
12.13.3 Novartis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Novartis Latest Developments
12.14 Genentech (Roche)
12.14.1 Company Information
12.14.2 Cancer Drug Therapy Product Offered
12.14.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Genentech (Roche) Latest Developments
12.15 Pfizer
12.15.1 Company Information
12.15.2 Cancer Drug Therapy Product Offered
12.15.3 Pfizer Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Pfizer Latest Developments
12.16 Exelixis
12.16.1 Company Information
12.16.2 Cancer Drug Therapy Product Offered
12.16.3 Exelixis Cancer Drug Therapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Exelixis Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cancer Drug Therapy Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Immunotherapy
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Table 9. Global Cancer Drug Therapy Revenue by Type (2015-2020) ($ million)
Table 10. Global Cancer Drug Therapy Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Cancer Drug Therapy Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Table 14. Global Cancer Drug Therapy Value by Application (2015-2020)
Table 15. Global Cancer Drug Therapy Value Market Share by Application (2015-2020)
Table 16. Global Cancer Drug Therapy Sale Price by Application (2015-2020)
Table 17. Global Cancer Drug Therapy Sales by Company (2017-2019) (K Units)
Table 18. Global Cancer Drug Therapy Sales Market Share by Company (2017-2019)
Table 19. Global Cancer Drug Therapy Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Cancer Drug Therapy Revenue Market Share by Company (2017-2019)
Table 21. Global Cancer Drug Therapy Sale Price by Company (2017-2019)
Table 22. Global Cancer Drug Therapy Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Cancer Drug Therapy Products Offered
Table 24. Cancer Drug Therapy Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Cancer Drug Therapy Consumption by Regions 2015-2020 (K Units)
Table 26. Global Cancer Drug Therapy Consumption Market Share by Regions 2015-2020
Table 27. Global Cancer Drug Therapy Value by Regions 2015-2020 ($ Millions)
Table 28. Global Cancer Drug Therapy Value Market Share by Regions 2015-2020
Table 29. Americas Cancer Drug Therapy Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Cancer Drug Therapy Consumption Market Share by Countries (2015-2020)
Table 31. Americas Cancer Drug Therapy Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Cancer Drug Therapy Value Market Share by Countries (2015-2020)
Table 33. Americas Cancer Drug Therapy Consumption by Type (2015-2020) (K Units)
Table 34. Americas Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Table 35. Americas Cancer Drug Therapy Consumption by Application (2015-2020) (K Units)
Table 36. Americas Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Table 37. APAC Cancer Drug Therapy Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Cancer Drug Therapy Consumption Market Share by Regions (2015-2020)
Table 39. APAC Cancer Drug Therapy Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Cancer Drug Therapy Value Market Share by Regions (2015-2020)
Table 41. APAC Cancer Drug Therapy Consumption by Type (2015-2020) (K Units)
Table 42. APAC Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Table 43. APAC Cancer Drug Therapy Consumption by Application (2015-2020) (K Units)
Table 44. APAC Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Table 45. Europe Cancer Drug Therapy Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Cancer Drug Therapy Consumption Market Share by Countries (2015-2020)
Table 47. Europe Cancer Drug Therapy Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Cancer Drug Therapy Value Market Share by Countries (2015-2020)
Table 49. Europe Cancer Drug Therapy Consumption by Type (2015-2020) (K Units)
Table 50. Europe Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Table 51. Europe Cancer Drug Therapy Consumption by Application (2015-2020) (K Units)
Table 52. Europe Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Cancer Drug Therapy Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Cancer Drug Therapy Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Cancer Drug Therapy Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cancer Drug Therapy Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Cancer Drug Therapy Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Table 61. Cancer Drug Therapy Distributors List
Table 62. Cancer Drug Therapy Customer List
Table 63. Global Cancer Drug Therapy Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Cancer Drug Therapy Consumption Market Forecast by Regions
Table 65. Global Cancer Drug Therapy Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Cancer Drug Therapy Value Market Share Forecast by Regions
Table 67. Global Cancer Drug Therapy Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Cancer Drug Therapy Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Cancer Drug Therapy Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Cancer Drug Therapy Value Market Share Forecast by Type (2021-2025)
Table 71. Global Cancer Drug Therapy Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Cancer Drug Therapy Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Cancer Drug Therapy Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Cancer Drug Therapy Value Market Share Forecast by Application (2021-2025)
Table 75. Amgen / Allergan Product Offered
Table 76. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. Amgen / Allergan Main Business
Table 78. Amgen / Allergan Latest Developments
Table 79. Amgen / Allergan Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Product Offered
Table 81. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Bristol-Myers Squibb Main Business
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Argos Therapeutics Product Offered
Table 86. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Argos Therapeutics Main Business
Table 88. Argos Therapeutics Latest Developments
Table 89. Argos Therapeutics Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Aveo Pharmaceuticals Product Offered
Table 91. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Aveo Pharmaceuticals Main Business
Table 93. Aveo Pharmaceuticals Latest Developments
Table 94. Aveo Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Product Offered
Table 96. Bayer Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Bayer Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca Product Offered
Table 101. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. AstraZeneca Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Product Offered
Table 106. Merck Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Merck Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Exelixis Product Offered
Table 111. Exelixis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Exelixis Main Business
Table 113. Exelixis Latest Developments
Table 114. Exelixis Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 115. Roche Product Offered
Table 116. Roche Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Roche Main Business
Table 118. Roche Latest Developments
Table 119. Roche Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Incyte Product Offered
Table 121. Incyte Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Incyte Main Business
Table 123. Incyte Latest Developments
Table 124. Incyte Basic Information, Company Total Revenue (in $ million), Cancer Drug Therapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Prometheus Labs Product Offered
Table 126. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Prometheus Labs Main Business
Table 128. Prometheus Labs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Prometheus Labs Latest Developments
Table 130. Eisai Product Offered
Table 131. Eisai Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Eisai Main Business
Table 133. Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Eisai Latest Developments
Table 135. Novartis Product Offered
Table 136. Novartis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Novartis Main Business
Table 138. Novartis Latest Developments
Table 139. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Genentech (Roche) Product Offered
Table 141. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. Genentech (Roche) Main Business
Table 143. Genentech (Roche) Latest Developments
Table 144. Genentech (Roche) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Pfizer Product Offered
Table 146. Pfizer Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 147. Pfizer Main Business
Table 148. Pfizer Latest Developments
Table 149. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Exelixis Product Offered
Table 151. Exelixis Cancer Drug Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 152. Exelixis Main Business
Table 153. Exelixis Latest Developments
Table 154. Exelixis Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cancer Drug Therapy
Figure 2. Cancer Drug Therapy Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Drug Therapy Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cancer Drug Therapy Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Targeted Therapy
Figure 7. Product Picture of Chemotherapy
Figure 8. Product Picture of Immunotherapy
Figure 9. Global Cancer Drug Therapy Consumption Market Share by Type (2015-2020)
Figure 10. Global Cancer Drug Therapy Value Market Share by Type (2015-2020)
Figure 11. Cancer Drug Therapy Consumed in Angiogenesis Inhibitors
Figure 12. Global Cancer Drug Therapy Market: Angiogenesis Inhibitors (2015-2020) (K Units)
Figure 13. Global Cancer Drug Therapy Market: Angiogenesis Inhibitors (2015-2020) ($ Millions)
Figure 14. Cancer Drug Therapy Consumed in mTOR Inhibitors
Figure 15. Global Cancer Drug Therapy Market: mTOR Inhibitors (2015-2020) (K Units)
Figure 16. Global Cancer Drug Therapy Market: mTOR Inhibitors (2015-2020) ($ Millions)
Figure 17. Cancer Drug Therapy Consumed in Monoclonal Antibodies
Figure 18. Global Cancer Drug Therapy Market: Monoclonal Antibodies (2015-2020) (K Units)
Figure 19. Global Cancer Drug Therapy Market: Monoclonal Antibodies (2015-2020) ($ Millions)
Figure 20. Cancer Drug Therapy Consumed in Cytokine Immunotherapy (IL-2)
Figure 21. Global Cancer Drug Therapy Market: Cytokine Immunotherapy (IL-2) (2015-2020) (K Units)
Figure 22. Global Cancer Drug Therapy Market: Cytokine Immunotherapy (IL-2) (2015-2020) ($ Millions)
Figure 23. Global Cancer Drug Therapy Consumption Market Share by Application (2015-2020)
Figure 24. Global Cancer Drug Therapy Value Market Share by Application (2015-2020)
Figure 25. Global Cancer Drug Therapy Sales Market Share by Company in 2017
Figure 26. Global Cancer Drug Therapy Sales Market Share by Company in 2019
Figure 27. Global Cancer Drug Therapy Revenue Market Share by Company in 2017
Figure 28. Global Cancer Drug Therapy Revenue Market Share by Company in 2019
Figure 29. Global Cancer Drug Therapy Sale Price by Company in 2019
Figure 30. Global Cancer Drug Therapy Consumption Market Share by Regions 2015-2020
Figure 31. Global Cancer Drug Therapy Value Market Share by Regions 2015-2020
Figure 32. Americas Cancer Drug Therapy Consumption 2015-2020 (K Units)
Figure 33. Americas Cancer Drug Therapy Value 2015-2020 ($ Millions)
Figure 34. APAC Cancer Drug Therapy Consumption 2015-2020 (K Units)
Figure 35. APAC Cancer Drug Therapy Value 2015-2020 ($ Millions)
Figure 36. Europe Cancer Drug Therapy Consumption 2015-2020 (K Units)
Figure 37. Europe Cancer Drug Therapy Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Cancer Drug Therapy Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Cancer Drug Therapy Value 2015-2020 ($ Millions)
Figure 40. Americas Cancer Drug Therapy Consumption Market Share by Countries in 2019
Figure 41. Americas Cancer Drug Therapy Value Market Share by Countries in 2019
Figure 42. Americas Cancer Drug Therapy Consumption Market Share by Type in 2019
Figure 43. Americas Cancer Drug Therapy Consumption Market Share by Application in 2019
Figure 44. United States Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 45. United States Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Cancer Drug Therapy Consumption Market Share by Countries in 2019
Figure 51. APAC Cancer Drug Therapy Value Market Share by Regions in 2019
Figure 52. APAC Cancer Drug Therapy Consumption Market Share by Type in 2019
Figure 53. APAC Cancer Drug Therapy Consumption Market Share by Application in 2019
Figure 54. China Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 55. China Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 62. India Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 63. India Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Cancer Drug Therapy Consumption Market Share by Countries in 2019
Figure 67. Europe Cancer Drug Therapy Value Market Share by Countries in 2019
Figure 68. Europe Cancer Drug Therapy Consumption Market Share by Type in 2019
Figure 69. Europe Cancer Drug Therapy Consumption Market Share by Application in 2019
Figure 70. Germany Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 72. France Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 73. France Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 74. UK Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 75. UK Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Cancer Drug Therapy Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Cancer Drug Therapy Consumption Market Share by Application in 2019
Figure 84. Egypt Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Cancer Drug Therapy Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Cancer Drug Therapy Value Growth 2015-2020 ($ Millions)
Figure 94. Global Cancer Drug Therapy Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Cancer Drug Therapy Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 97. Americas Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 98. APAC Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 99. APAC Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 100. Europe Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 101. Europe Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 104. United States Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 105. United States Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 106. Canada Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 107. Canada Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 108. Mexico Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 109. Mexico Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 110. Brazil Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 111. Brazil Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 112. China Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 113. China Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 114. Japan Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 115. Japan Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 116. Korea Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 117. Korea Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 120. India Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 121. India Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 122. Australia Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 123. Australia Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 124. Germany Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 125. Germany Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 126. France Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 127. France Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 128. UK Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 129. UK Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 130. Italy Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 131. Italy Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 132. Russia Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 133. Russia Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 134. Spain Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 135. Spain Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 136. Egypt Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 137. Egypt Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 138. South Africa Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 139. South Africa Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 140. Israel Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 141. Israel Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 142. Turkey Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 143. Turkey Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Cancer Drug Therapy Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Cancer Drug Therapy Value 2021-2025 ($ Millions)
Figure 146. Amgen / Allergan Cancer Drug Therapy Market Share (2018-2020)
Figure 147. Bristol-Myers Squibb Cancer Drug Therapy Market Share (2018-2020)
Figure 148. Argos Therapeutics Cancer Drug Therapy Market Share (2018-2020)
Figure 149. Aveo Pharmaceuticals Cancer Drug Therapy Market Share (2018-2020)
Figure 150. Bayer Cancer Drug Therapy Market Share (2018-2020)
Figure 151. AstraZeneca Cancer Drug Therapy Market Share (2018-2020)
Figure 152. Merck Cancer Drug Therapy Market Share (2018-2020)
Figure 153. Exelixis Cancer Drug Therapy Market Share (2018-2020)
Figure 154. Roche Cancer Drug Therapy Market Share (2018-2020)
Figure 155. Incyte Cancer Drug Therapy Market Share (2018-2020)
Figure 156. Prometheus Labs Cancer Drug Therapy Market Share (2018-2020)
Figure 157. Eisai Cancer Drug Therapy Market Share (2018-2020)
Figure 158. Novartis Cancer Drug Therapy Market Share (2018-2020)
Figure 159. Genentech (Roche) Cancer Drug Therapy Market Share (2018-2020)
Figure 160. Pfizer Cancer Drug Therapy Market Share (2018-2020)
Figure 161. Exelixis Cancer Drug Therapy Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets